U.S. Software Stock News

NYSE:EFC
NYSE:EFCMortgage REITs

Exploring 3 Undervalued Small Caps With Insider Action In Global Markets

As the U.S. market experiences mixed results with major indices like the S&P 500 and Dow Jones Industrial Average setting new records, small-cap stocks continue to garner attention amid economic uncertainties such as the ongoing government shutdown. In this dynamic environment, identifying promising small-cap opportunities often involves looking at companies with strong fundamentals and notable insider activity, which can signal confidence in their potential despite broader market challenges.
NYSE:GFF
NYSE:GFFBuilding

3 Stocks Estimated To Be Trading At Discounts Of Up To 42.8%

As the U.S. stock market navigates through a period of mixed performance with major indices setting new records despite challenges like a government shutdown, investors are keenly observing opportunities that may be undervalued amidst these fluctuations. In such an environment, identifying stocks that are trading at significant discounts can offer potential value, especially when considering broader economic factors and sector-specific developments.
NYSEAM:UAMY
NYSEAM:UAMYMetals and Mining

Discover Figure Technology Solutions And 2 More Insider-Favored Growth Stocks

In the current U.S. market landscape, major stock indexes have shown resilience with weekly gains despite mixed endings and external pressures such as a government shutdown affecting economic data releases. Amidst this backdrop, growth companies with high insider ownership can offer unique insights into potential value, as insiders often have intimate knowledge of their company's prospects and challenges.
NasdaqCM:SLSN
NasdaqCM:SLSNChemicals

US Market's Undiscovered Gems October 2025

As of October 2025, the U.S. stock market has shown resilience with major indices like the Dow Jones Industrial Average and S&P 500 setting new records, despite mixed performances and economic uncertainties stemming from a government shutdown. In this dynamic environment, identifying promising small-cap stocks can be particularly rewarding as these companies often offer unique growth opportunities that larger firms may not provide.
NYSE:BKKT
NYSE:BKKTCapital Markets

Does Bakkt (BKKT) Sharpening Its Digital Asset Focus Hint at a New Growth Strategy?

Bakkt Holdings recently completed the sale of its loyalty business and appointed fintech veteran Mike Alfred to its board, marking a shift to a focused digital asset infrastructure platform. This transformation is underscored by renewed emphasis on Bitcoin, tokenized payments, and zero debt, signaling a significant realignment toward crypto and digital finance services. We'll explore how the company’s sharpened focus on digital assets and new leadership shapes Bakkt Holdings' investment...
NasdaqGS:FULT
NasdaqGS:FULTBanks

Does Fulton Financial’s Recent Slip Offer an Opportunity After Latest Dividend Announcement?

If you are staring at Fulton Financial’s ticker and wondering what comes next, you are not alone. The stock has quietly caught the eye of both cautious and optimistic investors after years of solid, if occasionally bumpy, performance. While volatility has crept in recently, with the price slipping -2.9% in the past week and -5.3% over the last month, the longer-term story is hard to ignore. Shares are up 10% over the past year, and an impressive 118.3% over five years, which suggests that...
NYSE:ANRO
NYSE:ANROPharmaceuticals

Alto Neuroscience: Evaluating Valuation After FDA Fast Track Win for ALTO-101

Alto Neuroscience just received Fast Track designation from the FDA for ALTO-101, a new drug candidate aimed at treating cognitive impairment related to schizophrenia. This move could accelerate ALTO-101’s development and review process. See our latest analysis for Alto Neuroscience. The FDA’s support for ALTO-101 sparked fresh interest in Alto Neuroscience. However, despite the headline, its 1-year total shareholder return remains nearly flat while recent share price momentum has been...
NYSE:CHE
NYSE:CHEHealthcare

Is Chemed Poised for Rebound After 16% Drop and Q1 Revenue Miss?

Trying to decide what to do with Chemed stock right now? You are not alone. Shareholders and would-be investors alike have been watching the company’s journey with a mix of curiosity and concern. After all, Chemed’s story over the past year has not followed a gentle upward climb. Instead, it has seen some notable slides, including a 16.0% drop year-to-date and an even steeper 23.4% decline over the past 12 months. Even stretching out to five years, Chemed’s shares are down 5.9%, which can...
NYSE:AMH
NYSE:AMHResidential REITs

Analyzing American Homes 4 Rent Amid Recent Stock Slide and Rising Interest Rate Concerns

Thinking about your next move with American Homes 4 Rent? You are not alone. The real estate sector has kept investors guessing lately, and American Homes 4 Rent has seen its fair share of ups and downs. Over the past week, the stock held steady with a slight 0.1% bump, but the 30-day drop of 6.3% and a year-to-date slide of 11.2% might be giving some pause. Long-term holders have still netted a gain, with more than 22% over five years, but recent dips have many wondering whether there is...
NYSE:PRA
NYSE:PRAInsurance

How Investors Are Reacting To ProAssurance (PRA) Analyst Upgrade and Surge in Institutional Interest

In recent weeks, ProAssurance received a consensus "Hold" recommendation from six ratings firms, while Zacks Research raised its rating to "strong-buy" and institutional investors and hedge funds significantly increased their shareholdings. This combination of analyst upgrade and heightened institutional interest signals a shift in market sentiment and renewed confidence in the company’s outlook. We’ll examine how the increased institutional ownership may impact ProAssurance’s investment...
NasdaqGS:SLDE
NasdaqGS:SLDEInsurance

Is Slide Insurance Holdings Set for a Rebound After Recent 14.8% Price Surge?

If you have been eyeing Slide Insurance Holdings or already hold some shares, you are probably wondering whether now is a smart time to buy, sell, or simply sit tight. The stock has certainly been on the move, with prices rising 5.2% over the past week and up 14.8% in the last month. That momentum stands in stark contrast to its year-to-date performance, where shares are still down 22.3%. This kind of turnaround often hints at shifting investor sentiment, possibly tied to developments in the...